Evidence map›Paper›PMID 29321549›Full record

ArticleScientific reports2018

Probing the molecular basis of hERG drug block with unnatural amino acids.

Logan C Macdonald, Robin Y Kim, Harley T Kurata, David Fedida

Abstract read
In one paragraph

Article in Scientific reports, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Quercetin is a foe in the heart by targeting the hERG potassium channel.Iranian journal of basic medical sciences · 2024
    Article
  2. Article
  3. Genetic and Molecular Aspects of Drug-Induced QT Interval Prolongation.International journal of molecular sciences · 2021
    Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. An Update on the Structure of hERG.Frontiers in pharmacology · 2019
    Review
  10. Structural implications of hERG KThe Journal of biological chemistry · 2018
    Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Logan C MacdonaldDepartment of Anesthesiology, Pharmacology and Therapeutics, University of British Columbia, Vancouver, British Columbia, V6T 1Z3, Canada.
Robin Y KimDepartment of Pharmacology, University of Alberta, Edmonton, Alberta, T6G 2H7, Canada.
Harley T KurataDepartment of Pharmacology, University of Alberta, Edmonton, Alberta, T6G 2H7, Canada.ORCID http://orcid.org/0000-0003-4357-4189
David FedidaDepartment of Anesthesiology, Pharmacology and Therapeutics, University of British Columbia, Vancouver, British Columbia, V6T 1Z3, Canada. david.fedida@ubc.ca.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Repolarization of the cardiac action potential is primarily mediated by two voltage-dependent potassium currents: I

Indexed as

Amino AcidsAnimalsDrug DesignDrug DiscoveryERG1 Potassium ChannelHumansIon Channel GatingMolecular ConformationMolecular Docking SimulationMolecular Dynamics SimulationMolecular StructureMutationPhenylalaninePotassium Channel BlockersStructure-Activity RelationshipXenopus laevisAmino AcidsERG1 Potassium ChannelPhenylalaninePotassium Channel Blockers

Identifiers

PMID29321549
PMCPMC5762913

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.